Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Futura Medical ( (GB:FUM) ).
Futura Medical has announced a change in the voting rights held by Lombard Odier Asset Management (Europe) Limited, which now holds 28.01% of the company’s voting rights. This increase from a previous position of 27.96% signifies a slight shift in the stakeholder dynamics and could potentially influence future company decisions.
More about Futura Medical
Futura Medical PLC operates in the pharmaceutical industry, focusing on the development of innovative products for sexual health and pain management. The company is known for its topical formulations that utilize its proprietary DermaSys technology, aimed at improving the delivery and efficacy of active ingredients.
YTD Price Performance: 27.84%
Average Trading Volume: 672,062
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £99.01M
For a thorough assessment of FUM stock, go to TipRanks’ Stock Analysis page.
